DexCom, Inc. (DXCM)

74.43 +1.35 (+1.85%) USD  |  NASDAQ  |  Feb 23, 11:32
More

DexCom Cash from Other Financing Activities (Quarterly)

Cash from Other Financing Activities (Quarterly) Chart

View Cash from Other Financing Activities (Quarterly) for DXCM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Other Financing Activities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash from Other Financing Activities (Quarterly) Range, Past 5 Years

View Cash from Other Financing Activities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Other Financing Activities (Quarterly) Benchmarks

View Cash from Other Financing Activities (Quarterly) Benchmarks
Start Trial
BioLife Solutions, Inc. Upgrade
Abbott Laboratories Upgrade
Krystal Biotech, Inc. Upgrade
Boston Scientific Corp. Upgrade
Insulet Corp. Upgrade